Trial intelligence / Profile preview

Intralesional Botulinum Toxin Type A vs Saline for Scalp Psoriasis (Randomized Split-Side Double-Blind Placebo-Controlled)

TCTR20181214001Phase 3Recruiting

Sponsor
Royal College of Physicians of Thailand
Start
Jun 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of botulinum toxin type A in psoriasis (2 arms), sponsored by Royal College of Physicians of Thailand. Started Jun 2018; status: recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

psoriasis

Beyond the preview

Go deeper on TCTR20181214001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20181214001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call